
|Articles|August 17, 2016
Recordati Makes New Appointments Following Death of CEO
August 17, 2016
Advertisement
Following the death of its Chairman and Chief Executive Officer Giovanni Recordati this week, the board of Recordati (Milan, Italy) appointed Alberto Recordati as Chairman of the Board of Directors and Andrea Recordati as Vice Chairman and Chief Executive Officer.
Andrea has been Chief Operating Officer since 2013, in charge of the group’s commercial and production activities. Alberto Recordati has been responsible for drug discovery and development activities since 2008 and for licensing-in activities since 2011.
Giovanni Recordati had been Chief Executive Officer of the company since 1990.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
2
Why Integrated GMP Operating Models Are Reshaping Outsourced Manufacturing
3
The Retailization of Medicare Advantage: What Costco’s Entry Means for Pharma
4
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
5




